Skip to main content

Articles

Original Research
The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives
Stakeholder Perspective
The Challenge of Managing Specialty Drugs for Psoriasis
Read More
Biosimilars
Is a Biologic Produced 15 Years Ago a Biosimilar of Itself Today?
Read More
Multiple Myeloma, Oncology
The Evolution of Survivorship Care in Multiple Myeloma
Read More
Conference Correspondent, ASH 2016 - Multiple Myeloma
Findings from the Connect MM Registry: Changes in Treatment Patterns in Patients with Newly Diagnosed Multiple Myeloma
Read More
Conference Correspondent, ASH 2016 - Multiple Myeloma
Carfilzomib, Pomalidomide, and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma
Read More
Conference Correspondent, ASH 2016 - Multiple Myeloma
Elotuzumab, Lenalidomide, and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma
Read More
Conference Correspondent, ASH 2016 - Multiple Myeloma
Response-Adapted Therapy for Newly Diagnosed Myeloma
Read More
Conference Correspondent, ASH 2016 - Multiple Myeloma
Treatment with a Novel HDAC6 Inhibitor plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Read More
Conference Correspondent, ASH 2016 - Multiple Myeloma
Sustained Overall Survival in Patients with Smoldering Myeloma Receiving Lenalidomide-Based Therapy
Read More
Conference Correspondent, ASH 2016 - Multiple Myeloma
Lenalidomide Is a Highly Effective Maintenance Therapy in Myeloma Patients of All Ages
Read More
Page 101 of 245
Results 1001 - 1010 of 2441